This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Hmn (hereditary Motor Neuropathy) Proximal Type I
Information about Hmn (hereditary Motor Neuropathy) Proximal Type I: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Hmn (hereditary Motor Neuropathy) Proximal Type I
Most recent studies have shown that Hmn (hereditary Motor Neuropathy) Proximal Type I shares some biological mechanisms with amyotrophic-lateral-sclerosis, atrophy, demyelinating-diseases, dystrophy, juvenile-spinal-muscular-atrophy, motor-neuron-disease, muscle-contracture, muscle-hypotonia, muscle-weakness, muscular-atrophy, muscular-dystrophy, myopathy, nerve-degeneration, neuromuscular-diseases, sclerosis, spinal-cord-diseases, spinal-muscular-atrophies-of-childhood, spinal-muscular-atrophy, weakness.
Among the many pathways, these few ones have gauged particular interests from scientists studying Hmn (hereditary Motor Neuropathy) Proximal Type I, and have been seen in publications frequently: Cell Adhesion, Cell Death, Cell Proliferation, Dna Repair, Electron Transport, Fertilization, Innervation, Localization, Lung Development, Muscle Atrophy, Myelination, Neuron Death, Pathogenesis, Phagocytosis, Programmed Cell Death, Receptor Clustering, Reflex, Regeneration, Schwann Cell Proliferation, Transport
Quite a number of genes have been found to play important roles in Hmn (hereditary Motor Neuropathy) Proximal Type I, such as BCL2, BCL2L1, BDNF, CYCS, DES, DMD, GFAP, GTF2H2, IGFALS, IGHMBP2, MAP1B, NAIP, SLC1A2, SMN1, SNRPN, SOD1, STMN1, VIM. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.